Table of Contents
Introduction
Aetiology
Pathophysiology
aetiology and pathophysiology of atrial fibrillation
see also:
cardiology
cardiac arrhythmias
atrial flutter
atrial fibrillation
Pre-excitation syndrome such as WPW
see
Detailed Mx of the patient with AF in the ED
Introduction
lifestyle interventions, including weight loss and improved physical activity, have been shown to decrease AF risk in obese individuals.
Aetiology
most AF is related to high blood pressure, diabetes, and heart disease
~22% risk is genetic
1)
both rare and common genetic variants contribute to AF susceptibility
> 100 common variants associated with AF
individually rare, high-impact variants
protein-altering LMNA variants (PAVs) which encode the nuclear envelope protein Lamin A/C
these are associated with conduction system disease, AF, ventricular arrhythmias, and dilated cardiomyopathy
AF is highly prevalent and an early manifestation in LMNA-associated cardiomyopathy
hyperthyroidism
hypothyroidism
valvular heart disease
ethanol (alcohol and alcohol withdrawal)
- binge or regular drinking
high caffeine intake or other stimulants
smoking
hypertension
ischaemic heart disease (IHD)
stress
and
anxiety
dehydration
strenuous exertion
obesity
and metabolic syndrome
plays major roles in the pathophysiology of AF and its associated complications by inducing systemic changes, including altered haemodynamics, heightened sympathetic tone, and a persistent low-grade inflammatory state
2)
obstructive sleep apnoea (OSA)
congenital heart defects
cardiomyopathy
pericarditis
viral infections
sepsis / septicaemia
cardiac surgery
lung diseases including COPD, pneumonia,
lung cancer
diabetes mellitus
chronic renal failure
increasing age over 60yrs
FH AF
Pathophysiology
role of adipokines
Angiopoietin-like protein 2, Fibroblast growth factor 21, Lipocalin, Vaspin, Visfatin, and Nesfatin-1 play major roles in AF pathogenesis
3)
1)
2026: Gene-gene interactions between a LMNA variant and common polymorphisms drive early-onset atrial fibrillation
2)
,
3)
Cardiovascular Innovations and Applications 2024: Atrial Fibrillation and Adipokines: A Pathophysiological Perspective